Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 1 1

Status

Unknown 2Completed 2Withdrawn 1Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

NET 1Endocrine 1

Conditions

Oncogenic osteomalacia 1Neuroendocrine Tumors 1

Interventions

fludarabine 17Cyclophosphamide 16Positron Emission Tomography Computed Tomography 4Oncolytic Virotherapy 4Metformin 468Ga-pentixafor 4lenvatinib 3Radiosurgery 3Pemetrexed 3Paclitaxel 3Melphalan 3Immunotherapy, Adoptive 3Gemcitabine 3Cholestanetriol 26-Monooxygenase 3Carboplatin 3toripalimab 2sintilimab 2pembrolizumab 2gallium Ga 68 dotatate 2gallium 68 PSMA-11 2fludarabine phosphate 2alpha-Synuclein 2Progesterone 2Nivolumab 2Neoadjuvant Therapy 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Influenza Vaccines 2Fluorodeoxyglucose F18 2Ethiodized Oil 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × gallium Ga 68 dotatate × Clear all
NCT04041882 2019-08-01

68Ga-DOTATATE PET/CT in Neuroendocrine Tumor

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT01524016 2017-04-07

68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
100 enrolled

Oncogenic osteomalacia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡